Thorne Healthtech Stock

Thorne Healthtech ROE 2024

Thorne Healthtech ROE

0.11

Ticker

THRN

ISIN

US8852601090

In 2024, Thorne Healthtech's return on equity (ROE) was 0.11, a 242.11% increase from the 0.03 ROE in the previous year.

Thorne Healthtech Aktienanalyse

What does Thorne Healthtech do?

Thorne Healthtech Inc is a leading company in the health and wellness industry based in the USA. Founded in 1984 by Al Czap, a former Olympic champion and naturopath, Thorne Healthtech Inc has focused on producing high-quality dietary supplements. The history of Thorne Healthtech Inc began with the goal of improving people's health and well-being. The founder, Czap, believed that it was necessary to strengthen the body from the inside out to achieve long-term health. He started integrating naturopathic principles into his work and developing natural-based dietary supplements. Thorne Healthtech Inc's business model is based on the development and production of high-quality dietary supplements tailored to the needs of customers. The company has a strong research and development department that constantly develops new innovative products and improves existing ones. Thorne Healthtech Inc adheres to strict quality standards in manufacturing, and the products are produced under the supervision of experts. The company has divided itself into different divisions to offer customers a wide range of health products. One of the divisions is Performance Products, specifically tailored to athletes. This can include dietary supplements for post-workout recovery, collagen for joint health support, or supplements to enhance endurance and strength. Another division is Immune System Products. Here, Thorne Healthtech Inc offers a variety of dietary supplements designed to strengthen the immune system and protect the body against diseases and infections. This includes vitamins, herbs, minerals, and probiotic supplements. Another important area is Nutrient Supplements. Thorne Healthtech Inc produces a wide range of dietary supplements that can help provide the body with the necessary amount of nutrients. These include folic acid, magnesium, vitamin B12, and vitamin C. A particularly important area for the health industry is the Laboratory Tests sector. Thorne Healthtech Inc offers various tests for interested customers to better understand their health condition. These include tests for vitamins, minerals, probiotics, allergies, and more. In conclusion, Thorne Healthtech Inc is a company specialized in improving the physical and mental health of people through the production of high-quality dietary supplements. The company has a long history and extensive experience in naturopathy, and follows strict quality standards in product manufacturing. With a wide range of health and wellness products and excellent customer service, Thorne Healthtech Inc aims to support its customers in leading healthier lives. Thorne Healthtech ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROE Details

Decoding Thorne Healthtech's Return on Equity (ROE)

Thorne Healthtech's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Thorne Healthtech's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Thorne Healthtech's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Thorne Healthtech’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Thorne Healthtech stock

What is the ROE (Return on Equity) of Thorne Healthtech this year?

The ROE of Thorne Healthtech this year is 0.11 undefined.

How has the Return on Equity (ROE) of Thorne Healthtech developed compared to the previous year?

The ROE of Thorne Healthtech has increased by 242.11% increased compared to the previous year.

What impact does a high ROE (Return on Equity) have on investors of Thorne Healthtech?

A high ROE indicates that Thorne Healthtech generates good returns on capital and is successful in monetizing its investments. This is a positive indicator for investors.

What impact does a low ROE (Return on Equity) have on investors of Thorne Healthtech?

A low ROE can indicate that Thorne Healthtech is having difficulties monetizing its investments successfully and can be a negative signal for investors.

How does a change in the ROE (Return on Equity) of Thorne Healthtech affect the company?

A change in ROE (Return on Equity) of Thorne Healthtech can be an indicator of the financial performance of the company and demonstrate how successful the company is compared to other companies in the same industry.

How to calculate the ROE (Return on Equity) of Thorne Healthtech?

The ROE (Return on Equity) is calculated by dividing the company's profit by the total equity. The formula is: ROE = Profit / Total equity.

Which factors influence the ROE (Return on Equity) of Thorne Healthtech?

Some factors that can influence Thorne Healthtech's Return on Equity (ROE) include the efficiency in using equity, the profitability of the company, and the financing structure.

What strategic measures can take to improve the ROE (Return on Equity)?

To improve the Return on Equity (ROE), can take measures such as cost savings, increasing revenue, improving efficiency in the use of equity, and making changes in the financing structure. It is important for the company to conduct a thorough review of its financial situation to determine the best strategic actions to improve ROE.

How much dividend does Thorne Healthtech pay?

Over the past 12 months, Thorne Healthtech paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Thorne Healthtech is expected to pay a dividend of 0 USD.

What is the dividend yield of Thorne Healthtech?

The current dividend yield of Thorne Healthtech is .

When does Thorne Healthtech pay dividends?

Thorne Healthtech pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Thorne Healthtech?

Thorne Healthtech paid dividends every year for the past 0 years.

What is the dividend of Thorne Healthtech?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Thorne Healthtech located?

Thorne Healthtech is assigned to the 'Non-cyclical consumption' sector.

Wann musste ich die Aktien von Thorne Healthtech kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Thorne Healthtech from 12/18/2024 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 12/18/2024.

When did Thorne Healthtech pay the last dividend?

The last dividend was paid out on 12/18/2024.

What was the dividend of Thorne Healthtech in the year 2023?

In the year 2023, Thorne Healthtech distributed 0 USD as dividends.

In which currency does Thorne Healthtech pay out the dividend?

The dividends of Thorne Healthtech are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Thorne Healthtech

Our stock analysis for Thorne Healthtech Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Thorne Healthtech Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.